Middle East respiratory syndrome

• Published in: The Lancet (British edition) Vol. 395; no. 10229; pp. 1063 - 1077
• Main Authors: Memish, Ziad A, Perlman, Stanley, Van Kerkhove, Maria D, Zumla, Alimuddin
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 28.03.2020; Elsevier Limited
• Subjects: Adrenal Cortex Hormones - therapeutic use; Adult; Animals; Antibodies, Monoclonal - therapeutic use; Antiviral Agents - therapeutic use; Camelus; Child; Clinical Laboratory Techniques; Coronavirus Infections - epidemiology; Coronavirus Infections - prevention & control; Coronavirus Infections - transmission; Coronaviruses; COVID-19; Critical Care; Cross Infection - epidemiology; Cross Infection - prevention & control; Cross Infection - transmission; Drug development; Epidemics; Epidemiology; Fatalities; Female; Global Health; Hospitals; Humans; Immunity, Innate - physiology; Immunocompromised Host; Infection Control; Middle East respiratory syndrome; Middle East Respiratory Syndrome Coronavirus; Mortality; Nosocomial infection; Outbreaks; Pathogenesis; Pathogens; Plasma; Pregnancy; Pregnancy Complications, Infectious - epidemiology; Pregnancy Complications, Infectious - prevention & control; Respiratory diseases; Risk Factors; Seminar; Travel; Vaccines; Viral Vaccines; Zoonoses; Zoonoses - transmission; Middle East; Saudi Arabia; Arabian Peninsula; South Korea; China

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2...